InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by MILLER RICHARD A MD, Chief Executive Officer. Officer active across 1 company, notably Corvus Pharmaceuticals, Inc.. Aggregated, 8 reports have been published. Split: 8 buys · 0 sell. Total volume traded: €264k. Activity tracked since 4 May 2021. The latest transaction was filed on 24 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
5,000 shares@ US$1.030.0005% mcap1.9% of flowCommon StockSEC:0001567619-22-013465:0
Ideal exit: 21 Mar 2023 (T+270)
4,830 shares@ US$0.980.0004% mcap1.7% of flowCommon StockSEC:0001567619-22-012396:0
Ideal exit: 27 Feb 2023 (T+270)
15,000 shares@ US$1.63560.0021% mcap8.4% of flowCommon StockSEC:0001567619-22-007839:0
Ideal exit: 26 Dec 2022 (T+270)
25,000 shares@ US$1.4660.0032% mcap12.7% of flowCommon StockSEC:0001567619-22-007172:0
Ideal exit: 10 Dec 2022 (T+270)
10,000 shares@ US$1.925416.5% of flowCommon StockSEC:0001567619-21-016250
Ideal exit: 17 May 2022 (T+270)
10,000 shares@ US$1.92540.0016% mcap6.2% of flowCommon StockSEC:0001567619-21-016250:0
Ideal exit: 17 May 2022 (T+270)
35,714 shares@ US$2.8031.5% of flowCommon StockSEC:0001567619-21-009124
Ideal exit: 29 Jan 2022 (T+270)
35,714 shares@ US$2.800.0080% mcap31.5% of flowCommon StockSEC:0001567619-21-009124:0
Ideal exit: 29 Jan 2022 (T+270)
8 of 8 declarations
About MILLER RICHARD A MD
MILLER RICHARD A MD serves as President and CEO at Corvus Pharmaceuticals, Inc. He is responsible for the strategic direction of the company and the management of its daily operations. Under his leadership, Corvus Pharmaceuticals is committed to developing innovative treatments for serious diseases. MILLER RICHARD A MD plays a crucial role in defining the company's vision and establishing strong relationships with investors and partners.
